The growing demand of high potency drugs (HPAPIs) has meant an increasing focus on their development, rapid scaling, validation and production.
Discussing strategies on containment, scalability and safety of those compounds is imperative to support their growing demand and to overcome challenges within the industry. During this year’s conference, Sean Codling, CTS Managing director, presented a case study about the current challenges and compromises of laboratory containment.